Transfer pricing requires evidence for AMP transactions, functionally reliable comparables, and appropriate aggregation or Berry Ratio benchmarking me...
Revisionary jurisdiction cannot reopen share capital assessments where adequate inquiry supports a permissible view and no independent error is establ...
Reassessment jurisdiction fails where unverified portal information is aggregated without examining the taxpayer's explanation or relevance of entries...
Statutory sanction for delayed reassessment requires approval from the prescribed authority; approval by an inferior authority invalidates jurisdictio...
Transfer pricing margin adjustments require matching treatment of non-operating income and related costs, with comparability issues reconsidered on ev...
Preliminary-expense amortisation and MAT exempt-income adjustments prevailed, while trademark costs and managerial remuneration require fresh verifica...
Export valuation requires contemporaneous evidence; unrelated invoices cannot prove overvaluation, and dual penalties on firm and partner are impermis...
The AAR ruled on GST exemption applicability for medical supplies under N/N. 1/2017-Central Tax (Rate). For inpatients, medicines and medical supplies naturally bundled with healthcare services qualify as composite supply, making the entire transaction GST-exempt under Entry 74 of Notification 12/2017. For outpatients receiving treatment within hospital premises (dialysis, chemotherapy, minor surgeries), supplies remain exempt when naturally bundled with healthcare services, as law creates no distinction between inpatients and outpatients. However, medicines prescribed for home consumption and follow-up care are taxable, as hospital involvement is limited to prescribing without continuous treatment supervision, failing to constitute composite supply. When GST is collected on exempt supplies, it must be remitted per Section 76 CGST Act 2017.
The AAR ruled on GST exemption applicability for medical supplies under N/N. 1/2017-Central Tax (Rate). For inpatients, medicines and medical supplies naturally bundled with healthcare services qualify as composite supply, making the entire transaction GST-exempt under Entry 74 of Notification 12/2017. For outpatients receiving treatment within hospital premises (dialysis, chemotherapy, minor surgeries), supplies remain exempt when naturally bundled with healthcare services, as law creates no distinction between inpatients and outpatients. However, medicines prescribed for home consumption and follow-up care are taxable, as hospital involvement is limited to prescribing without continuous treatment supervision, failing to constitute composite supply. When GST is collected on exempt supplies, it must be remitted per Section 76 CGST Act 2017.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 4800
Join Channel
TaxTMI 
